Back
Viking Therapeutics Stock Price Chart
A massive $1 Trillion AI superproject is underway
Click here to discover these key companies behind this $1 trillion Superproject
Sell
47
VKTX
Viking Therapeutics
Last Price:
52.96
Seasonality Move:
1.76%
7 Day Trial
ALL ACCESS PASS
$
7
Free 23-page book shares my #1 indicator to use
Here's the 23-page free book.- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and VKTX is experiencing slight buying pressure.
Viking Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 50.6 | Buy |
| 20-day SMA: | 53.66 | Sell |
| 50-day SMA: | 63.66 | Sell |
| 200-day SMA: | 39.18 | Buy |
| 8-day EMA: | 51.13 | Buy |
| 20-day EMA: | 54.21 | Sell |
| 50-day EMA: | 59.37 | Sell |
| 200-day EMA: | 45.7 | Buy |
Viking Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -3.9 | Sell |
| Relative Strength Index (14 RSI): | 43.41 | Sell |
| Chaikin Money Flow: | 113403 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (50.34 - 60.74) | Sell |
| Bollinger Bands (100): | (47.23 - 79.29) | Sell |
Viking Therapeutics Technical Analysis
| Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 28 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | ||||||||||
| 14 | 17 | 18 | 20 | 21 | 24 | 25 | 26 | 27 | 28 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Viking Therapeutics Stock
Is Viking Therapeutics Stock a Buy?
- Viking Therapeutics share price is 52.96 while VKTX 8-day simple moving average is 50.60, which is a Buy signal.
- The stock price of VKTX is 52.96 while Viking Therapeutics 20-day SMA is 53.66, which makes it a Sell.
- Viking Therapeutics 50-day simple moving average is 63.66 while VKTX share price is 52.96, making it a Sell technically.
- VKTX stock price is 52.96 and Viking Therapeutics 200-day simple moving average is 39.18, creating a Buy signal.
VKTX Technical Analysis vs Fundamental Analysis
Sell
47
Viking Therapeutics (VKTX)
is a Sell
Is Viking Therapeutics a Buy or a Sell?
-
Viking Therapeutics stock is rated a Sell
The current Viking Therapeutics [VKTX] share price is $52.96. The Score for VKTX is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
Viking Therapeutics Stock Info
Market Cap:
5.84B
Price in USD:
52.96
Share Volume:
7.09M
Viking Therapeutics 52-Week Range
52-Week High:
99.41
52-Week Low:
8.28
Sell
47
Viking Therapeutics (VKTX)
is a Sell
Viking Therapeutics Share Price Forecast
-
What is the Viking Therapeutics stock price today?
The Viking Therapeutics stock price is 52.96 USD today. -
Will VKTX stock go up or go down?
Viking Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Viking Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Viking Therapeutics is overvalued.
Is Viking Therapeutics Stock a Buy?
- Viking Therapeutics share price is 52.96 while VKTX 8-day exponential moving average is 51.13, which is a Buy signal.
- The stock price of VKTX is 52.96 while Viking Therapeutics 20-day EMA is 54.21, which makes it a Sell.
- Viking Therapeutics 50-day exponential moving average is 59.37 while VKTX share price is 52.96, making it a Sell technically.
- VKTX stock price is 52.96 and Viking Therapeutics 200-day simple moving average is 45.70, creating a Buy signal.
Fundamental Analysis of Viking Therapeutics
Is Viking Therapeutics a good investment?
- Analysts estimate an earnings decrease this quarter of $0.06 per share, an increase next quarter of $0.00 per share, a decrease this year of $0.18 per share, and a decrease next year of $0.43 per share.
Technical Analysis of Viking Therapeutics
Should I short Viking Therapeutics stock?
- VKTX Moving Average Covergence Divergence (MACD) indicator is -3.9, suggesting Viking Therapeutics is a Sell
- Viking Therapeutics Relative Strength Index (RSI) is 43.41, which suggest Viking Therapeutics is oversold
- The Bollinger Bands (25) for Viking Therapeutics is (50.34 - 60.74), which suggest Viking Therapeutics is a Sell
- The Bollinger Bands (100) for Viking Therapeutics is (47.23 - 79.29), which suggest Viking Therapeutics is a Sell
* Viking Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.